1 completed, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
Follow Interview: new trials by email Literature Review of Interview trials Research Report on Interview
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients Best Practice, Electronic Health Record Review, Interview - Advanced Malignant Solid Neoplasm, Delirium | Phase 4 | Withdrawn | Mayo Clinic | 2025-02-26 | 2025-05-01 | |
| Home Based Daratumumab Administration for Patients With Multiple Myeloma Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life Assessment - Plasma Cell Myeloma | Phase 4 | Completed | Thomas Jefferson University | 20 | 2022-11-08 | 2025-11-21 |
Delirium (1) · Multiple Myeloma (1) · Sleep Initiation and Maintenance Disorders (1)
Mayo Clinic (1) · Thomas Jefferson University (1)
United States (2)
Adam R Binder, MD (1) · Regina M. Mackey, MD (1)